Close

TTLL12

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

TTLL12 (Tubulin Tyrosine Ligase Like 12) is a Protein Coding gene.
  • CAR Vector Products

  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

  • DMAb

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-LY933 Anti-TTLL12 (12B7) h(41BB-CD3ζ) CAR, pCDCAR1 Human 12B7 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY934 Anti-TTLL12 (1A2) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1A2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY935 Anti-TTLL12 (1D3) h(41BB-CD3ζ) CAR, pCDCAR1 Human 1D3 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY936 Anti-TTLL12 (2H10) h(41BB-CD3ζ) CAR, pCDCAR1 Human 2H10 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY937 Anti-TTLL12 (3H6) h(41BB-CD3ζ) CAR, pCDCAR1 Human 3H6 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY938 Anti-TTLL12 (4B2) h(41BB-CD3ζ) CAR, pCDCAR1 Human 4B2 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY939 Anti-TTLL12 (4E3) h(41BB-CD3ζ) CAR, pCDCAR1 Human 4E3 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY940 Anti-TTLL12 (5H3) h(41BB-CD3ζ) CAR, pCDCAR1 Human 5H3 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY941 Anti-TTLL12 (6E4) h(41BB-CD3ζ) CAR, pCDCAR1 Human 6E4 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY942 Anti-TTLL12 (7F11) h(41BB-CD3ζ) CAR, pCDCAR1 Human 7F11 Mouse scFv-41BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2573 Anti-TTLL12(12B7) h(CD28-CD3ζ) CAR, pCDCAR1 Human 12B7 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2574 Anti-TTLL12(1A2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1A2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2575 Anti-TTLL12(1D3) h(CD28-CD3ζ) CAR, pCDCAR1 Human 1D3 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2576 Anti-TTLL12(2H10) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2H10 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2577 Anti-TTLL12(3H6) h(CD28-CD3ζ) CAR, pCDCAR1 Human 3H6 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2578 Anti-TTLL12(4B2) h(CD28-CD3ζ) CAR, pCDCAR1 Human 4B2 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2579 Anti-TTLL12(4E3) h(CD28-CD3ζ) CAR, pCDCAR1 Human 4E3 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2580 Anti-TTLL12(5H3) h(CD28-CD3ζ) CAR, pCDCAR1 Human 5H3 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2581 Anti-TTLL12(6E4) h(CD28-CD3ζ) CAR, pCDCAR1 Human 6E4 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-LY2582 Anti-TTLL12(7F11) h(CD28-CD3ζ) CAR, pCDCAR1 Human 7F11 Mouse scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.